Skip to Content
 

VICC toll-free number 1-877-936-8422

Gynecologic Cancers

Vanderbilt Ingram Cancer Center's Division of Gynecologic Oncology specializes in the prevention, diagnosis and treatment of gynecologic malignancy, including ovarian cancer, cervical cancer, and endometrial cancer.

Clinical Trials for Gynecologic Cancers

10 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Treatment

Gynecologic
Uterine

NRGGYNGY006

11/29/2017

A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer

Treatment

Bladder
Kidney (Renal Cell)
Uterine

VICCURO16158

09/07/2017

A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (ANTI−PD-L1 Antibody) as Monotherapy and in Combination with Platinum-Based Chemotherapy in Patients with Untreated Locally Advanced or Metastatic Urothelial Carcinoma

Treatment

Cervical

VICCGYN16105

06/26/2017

Phase III Study of ADXS11-001 Administered Following Chemoradiation As Adjuvant Treatment For High Risk Locally Advanced Cervical Cancer

Treatment

Ovarian

VICCGYN16132

06/06/2017

PiSARRO: p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin/Pegylated Liposomal Doxorubicin Combination Chemotherapy With or Without APR-246

Treatment

Endocrine
Lung
Non Small Cell
Ovarian

VICCTHO1722

05/26/2017

Phase I Study of TRC102 in Combination with Cisplatin and Pemetrexed in Patients with Advanced Solid Tumors, with Expansion Cohort in Mesothelioma / Phase II Study of TRC102 with Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin

Treatment

Kidney (Renal Cell)
Lung
Melanoma
Miscellaneous
Non Small Cell
Ovarian
Uterine

VICCPHI1676

11/04/2016

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01949 in Subjects with Advanced or Metastatic Solid Tumors

Treatment

Kidney (Renal Cell)
Lung
Melanoma
Miscellaneous
Non Small Cell
Uterine

VICCPHI1634

08/30/2016

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01876 in Subjects with Advanced or Metastatic Solid Tumors

Treatment

Colon
Head/Neck
Lung
Lymphoma
Melanoma
Non Small Cell
Ovarian
Rectal

VICCPHI1531

03/01/2016

A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers

Treatment

Gynecologic
Ovarian

VICCGYN1492

06/16/2015

A Randomized, Open-Label Study Comparing the Combination of YONDELIS? and DOXIL?/CAELYX? With DOXIL?/CAELYX? Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Treatment

Bladder
Colon
Esophageal
Gastric/Gastroesophageal
Neuro-Oncology
Ovarian
Urologic
Uterine

VICCMD1403

06/02/2014

An Open Label, Phase II Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification